Coagulopathy Caused by Intrauterine Dextran

Thromb Haemost 1994; 71(03): 397-398
DOI: 10.1055/s-0038-1642449

Letter to the editor

Schattauer GmbH Stuttgart

P McPhedran

Yale New Haven Hospital, New Haven, CT, USA

,

D B Seifer

Yale New Haven Hospital, New Haven, CT, USA

,

L P Clyne

Yale New Haven Hospital, New Haven, CT, USA

,

D Ingbar

Yale New Haven Hospital, New Haven, CT, USA

References
1 Bergqvist D. Dextran and haemostasis. Acta Chir Scand 1982; 148: 633-40
2 Mangar D, Gerson JI, Constantine RM. Pulmonary edema and coagulopathy due to Hyskon® (32% Dextran 70) administration. Anesth Analg 1989; 68: 686-7
3 Jedeikin R, Olsfanger D, Kessler I. Disseminated intravascular coagulation and adult respiratory distress syndrome - life threatening complications of hysteroscopy. Am J Obstet Gynecol 1990; 162: 44-5
4 Choban MJ, Kalhan SB, Anderson RH, Collins R. Pulmonary edema and coagulopathy following intrauterine instillation of 32% dextran-70 (Hyskon). J Clin Anesth 1991; 3: 317-9
5 Åberg M, Pausing A. The effect of dextran-70 on the structure of ex-vivo thrombi. Thromb Res 1978; 12: 1113-23
6 Carlin G, Saldeen T. On the interaction between dextran and the fibrinolysis inhibitor α2-antiplasmin. Thromb Res 1980; 19: 103-10
7 Batlle J, deRio J, López-Fernández MF, Martin R, López-Borrasca A. Effect of dextran on factor VUI/von Willebrand structure and function. Thromb Haemostas 1985; 54: 697-9